Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

AI finds signs of pancreatic cancer

Digest more
Top News
Overview
 · 31m
AI finds signs of pancreatic cancer before tumors develop
By the time doctors detect pancreatic cancer, it’s often too late to treat effectively.

Continue reading

 · 15h
AI aiding in early detection of pancreatic cancer, Mayo Clinic says
 · 1d · on MSN
How AI is spotting pancreatic cancer signals that most doctors miss
 · 1d
A.I. tool could help detect deadly pancreatic cancer, Mayo Clinic says
REDMOD, an artificial intelligence system, analyzes CT scans to find subtle signs of the cancer before tumors are visible.

Continue reading

Post-Bulletin · 22h
Mayo Clinic researchers publish critical studies on Alzheimer's, weight loss, early cancer detection
 · 1d
Mayo Clinic develops AI tool that detects pancreatic cancer up to 3 years earlier

FDA, pancreatic cancer and expanded access

Digest more
Top News
Overview
 · 15h
FDA expands access to pancreatic cancer drug helping patients like Ben Sasse
The Food and Drug Administration said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved for use.

Continue reading

 · 14h · on MSN
FDA authorizes early access for experimental pancreatic cancer pill
 · 16h · on MSN
FDA green lights early access to pancreatic cancer drug, daraxonrasib
 · 13h
For pancreatic cancer, the FDA grants early access to the experimental drug daraxonrasib
Former U.S. Sen. Ben Sasse, R-Neb., is among those already being treated with the experimental pancreatic cancer drug.

Continue reading

 · 14h
FDA expands access to drug helping pancreatic cancer patients
 · 18h
Revolution Medicines wins FDA nod to provide early access to cancer therapy
Smithsonian Magazine
2d

Cancer Survivors Are Living Longer but Still Have Complex Needs. That’s Why Doctors and Advocates Want Post-Treatment Care Plans

Survivors have a heightened risk of developing cardiovascular disease, pain, insomnia, psychosocial distress and new cancers. Many, patient advocates say, are not receiving adequate long-term care
Pancreatic Cancer Action Network
4d

The Turning Point in Pancreatic Cancer is Here

PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer research – we are on the threshold of a new era of treatments for patients thanks to years of investment in research and advocacy.
2d

To catch colorectal cancer early, advocates push to make 'poop talk' OK

It's a very treatable form of cancer if caught early, yet younger adults rarely get screened. Patient advocates want more people to talk to their doctors about risk factors and number two.
Healthline
15h

Cardiovascular-Kidney-Metabolic Syndrome Tied to Major Risk for Cancer

People with cardiovascular-kidney-metabolic (CKM) syndrome have a higher risk of developing cancer, according to a new study. Experts say that adopting healthy lifestyle habits can help offer some protection.
5h

Lung cancer diagnoses in nonsmokers increasingly common: Author

Shira Kupperman Boehler says young women with no history of tobacco use are developing lung cancer at alarming rates.
4don MSN

Inside N.J.’s new $225M cancer center, designed to feel more like a resort than a hospital

RWJBarnabas Health and Rutgers Cancer Institute, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, are opening a new outpatient cancer care facility in North Jersey. The $225 million Melchiorre Cancer Center at Cooperman Barnabas Medical Center in Livingston is expected to open in June.
1d

Advancing Cancer Research Through Individualized Neoantigen Therapies

Recognizing this individuality has driven scientists to research beyond a one-size-fits-all approach to cancer treatment. With the arrival of technology advances in next-gen sequencing (NGS) and deterministic algorithms,
18h

One scan, one chance: A lung cancer screening saved this nonsmoker’s life

At 43, Shira Boehler was everything the modern health narrative celebrates: disciplined, active, a 6-mile runner, and critically, in the eyes of the medical system, someone who had never smoked.
  • Privacy
  • Terms